185 related articles for article (PubMed ID: 36139924)
1. Antibiotic Consumption Patterns in European Countries Are Associated with the Prevalence of Parkinson's Disease; the Possible Augmenting Role of the Narrow-Spectrum Penicillin.
Ternák G; Németh M; Rozanovic M; Márovics G; Bogár L
Antibiotics (Basel); 2022 Aug; 11(9):. PubMed ID: 36139924
[TBL] [Abstract][Full Text] [Related]
2. Dysbiosis in Parkinson's disease might be triggered by certain antibiotics.
Ternák G; Kuti D; Kovács KJ
Med Hypotheses; 2020 Apr; 137():109564. PubMed ID: 31954994
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic Consumption Patterns in European Countries Might Be Associated with the Prevalence of Type 1 and 2 Diabetes.
Ternák G; Németh M; Rozanovic M; Bogár L
Front Endocrinol (Lausanne); 2022; 13():870465. PubMed ID: 35600582
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic Consumption Patterns in European Countries May Be Associated with the Incidence of Major Carcinomas.
Ternák G; Berényi K; Sümegi A; Szenczi Á; Fodor B; Németh B; Kiss I
Antibiotics (Basel); 2020 Sep; 9(10):. PubMed ID: 32993020
[TBL] [Abstract][Full Text] [Related]
5. "Growth-Promoting Effect" of Antibiotic Use Could Explain the Global Obesity Pandemic: A European Survey.
Ternák G; Németh M; Rozanovic M; Márovics G; Bogár L
Antibiotics (Basel); 2022 Sep; 11(10):. PubMed ID: 36289981
[TBL] [Abstract][Full Text] [Related]
6. Association of antibiotic-consumption patterns with the prevalence of hematological malignancies in European countries.
Ternák G; Berényi K; Németh B; Szenczi Á; Márovics G; Kiss I
Sci Rep; 2022 May; 12(1):7821. PubMed ID: 35550556
[TBL] [Abstract][Full Text] [Related]
7. Down-Syndrome-Related Maternal Dysbiosis Might Be Triggered by Certain Classes of Antibiotics: A New Insight into the Possible Pathomechanisms.
Ternák G; Márovics G; Sümegi K; Bánfai Z; Büki G; Magyari L; Szabó A; Melegh B
Antibiotics (Basel); 2023 Jun; 12(6):. PubMed ID: 37370348
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's Disease-Related Dysbiosis Might Be Triggered by Certain Classes of Antibiotics with Time-Lapse: New Insights into the Pathogenesis?
Ternák G; Németh M; Rozanovic M; Bogár L
J Alzheimers Dis; 2022; 87(1):443-451. PubMed ID: 35275547
[TBL] [Abstract][Full Text] [Related]
9. Dominant Antibiotic Consumption Patterns Might Be Associated With the Prevalence of Multiple Sclerosis in European Countries.
TernÁk G; BerÉnyi K; MÁrovics G; SÜmegi A; Fodor B; NÉmeth B; Kiss I
In Vivo; 2020; 34(6):3467-3472. PubMed ID: 33144455
[TBL] [Abstract][Full Text] [Related]
10. Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease.
Koutzoumis DN; Vergara M; Pino J; Buddendorff J; Khoshbouei H; Mandel RJ; Torres GE
Exp Neurol; 2020 Mar; 325():113159. PubMed ID: 31843492
[TBL] [Abstract][Full Text] [Related]
11. Implications of the Gut Microbiome in Parkinson's Disease.
Elfil M; Kamel S; Kandil M; Koo BB; Schaefer SM
Mov Disord; 2020 Jun; 35(6):921-933. PubMed ID: 32092186
[TBL] [Abstract][Full Text] [Related]
12. Association of Parkinson's Disease With Microbes and Microbiological Therapy.
Chen ZJ; Liang CY; Yang LQ; Ren SM; Xia YM; Cui L; Li XF; Gao BL
Front Cell Infect Microbiol; 2021; 11():619354. PubMed ID: 33763383
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic exposure and risk of Parkinson's disease in Finland: A nationwide case-control study.
Mertsalmi TH; Pekkonen E; Scheperjans F
Mov Disord; 2020 Mar; 35(3):431-442. PubMed ID: 31737957
[TBL] [Abstract][Full Text] [Related]
14. The Link between Gut Dysbiosis and Neuroinflammation in Parkinson's Disease.
Baizabal-Carvallo JF; Alonso-Juarez M
Neuroscience; 2020 Apr; 432():160-173. PubMed ID: 32112917
[TBL] [Abstract][Full Text] [Related]
15. Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
GBD 2016 Parkinson's Disease Collaborators
Lancet Neurol; 2018 Nov; 17(11):939-953. PubMed ID: 30287051
[TBL] [Abstract][Full Text] [Related]
16. A national registry to determine the distribution and prevalence of Parkinson's disease in Thailand: implications of urbanization and pesticides as risk factors for Parkinson's disease.
Bhidayasiri R; Wannachai N; Limpabandhu S; Choeytim S; Suchonwanich Y; Tananyakul S; Tharathep C; Panjapiyakul P; Srismith R; Chimabutra K; Phanthumchinda K; Asawavichienjinda T
Neuroepidemiology; 2011; 37(3-4):222-30. PubMed ID: 22133707
[TBL] [Abstract][Full Text] [Related]
17. Parkinson's Disease and Gut Microbiota.
Hirayama M; Ohno K
Ann Nutr Metab; 2021; 77 Suppl 2():28-35. PubMed ID: 34500451
[TBL] [Abstract][Full Text] [Related]
18. Impact of gene mutation in the development of Parkinson's disease.
Selvaraj S; Piramanayagam S
Genes Dis; 2019 Jun; 6(2):120-128. PubMed ID: 31193965
[TBL] [Abstract][Full Text] [Related]
19. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
Rolinski M; Fox C; Maidment I; McShane R
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
[TBL] [Abstract][Full Text] [Related]
20. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
